# Nuvera Communications, Inc.: financial statements, quarterly

NUVR · OTC · CIK 71557 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nuvr.md) · [Financials](/companies/nuvr/financials.md) · [Filings](/companies/nuvr/filings.md) · [Insiders](/companies/nuvr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nuvr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.2](/filings/0001437749-24-035032.md) | [13.0 d](/filings/0001437749-25-007871.md) | [13.3](/filings/0001437749-25-016972.md) | [13.5](/filings/0001437749-25-026750.md) | [13.1](/filings/0001437749-25-034992.md) | [12.8 d](/filings/0001437749-26-008309.md) | [13.3](/filings/0001437749-26-017220.md) | [13.2](/filings/0001437749-26-027827.md) | [13.6](/filings/0001437749-25-034992.md) | [13.3 d](/filings/0001437749-26-008309.md) | [13.9](/filings/0001437749-26-017220.md) | [13.6](/filings/0001437749-26-027827.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [2.4](/filings/0001437749-24-035032.md) | [2.3 d](/filings/0001437749-25-007871.md) | [2.9](/filings/0001437749-25-016972.md) | [2.8](/filings/0001437749-25-026750.md) | [2.5](/filings/0001437749-25-034992.md) | [2.3 d](/filings/0001437749-26-008309.md) | [3.0](/filings/0001437749-26-017220.md) | [3.0](/filings/0001437749-26-027827.md) | [2.6](/filings/0001437749-25-034992.md) | [2.8 d](/filings/0001437749-26-008309.md) | [2.9](/filings/0001437749-26-017220.md) | [2.8](/filings/0001437749-26-027827.md) |
| Operating income | $m | [2.3](/filings/0001437749-24-035032.md) | [2.9 d](/filings/0001437749-25-007871.md) | [1.9](/filings/0001437749-25-016972.md) | [2.0](/filings/0001437749-25-026750.md) | [2.8](/filings/0001437749-25-034992.md) | [3.2 d](/filings/0001437749-26-008309.md) | [2.4](/filings/0001437749-26-017220.md) | [2.2](/filings/0001437749-26-027827.md) | [2.5](/filings/0001437749-25-034992.md) | [2.7 d](/filings/0001437749-26-008309.md) | [3.4](/filings/0001437749-26-017220.md) | [2.6](/filings/0001437749-26-027827.md) |
| Interest expense | $m | [2.0](/filings/0001513162-23-000144.md) | [2.1 d](/filings/0001513162-24-000033.md) | [2.5](/filings/0001513162-24-000057.md) | [2.6](/filings/0001437749-25-026750.md) | [3.1](/filings/0001437749-25-034992.md) | [3.1 d](/filings/0001437749-26-008309.md) | [(0.1)](/filings/0001437749-26-017220.md) | [(0.0)](/filings/0001437749-26-027827.md) | [3.1](/filings/0001437749-25-034992.md) | [3.1 d](/filings/0001437749-26-008309.md) | [(0.1)](/filings/0001437749-26-017220.md) | [(0.0)](/filings/0001437749-26-027827.md) |
| Income tax | $m | [0.2](/filings/0001437749-24-035032.md) | [0.3 d](/filings/0001437749-25-007871.md) | [0.3](/filings/0001437749-25-016972.md) | [(0.2)](/filings/0001437749-25-026750.md) | [0.0](/filings/0001437749-25-034992.md) | [0.2 d](/filings/0001437749-26-008309.md) | [0.4](/filings/0001437749-26-017220.md) | [(0.2)](/filings/0001437749-26-027827.md) | [(0.1)](/filings/0001437749-25-034992.md) | [0.1 d](/filings/0001437749-26-008309.md) | [0.6](/filings/0001437749-26-017220.md) | [(0.1)](/filings/0001437749-26-027827.md) |
| Net income | $m | [0.5](/filings/0001437749-24-035032.md) | [(8.4) d](/filings/0001437749-25-007871.md) | [0.7](/filings/0001437749-25-016972.md) | [(0.4)](/filings/0001437749-25-026750.md) | [0.1](/filings/0001437749-25-034992.md) | [(4.8) d](/filings/0001437749-26-008309.md) | [1.0](/filings/0001437749-26-017220.md) | [(0.4)](/filings/0001437749-26-027827.md) | [(0.2)](/filings/0001437749-25-034992.md) | [(0.0) d](/filings/0001437749-26-008309.md) | [1.6](/filings/0001437749-26-017220.md) | [(0.2)](/filings/0001437749-26-027827.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001437749-24-035032.md) | not reported | [0.14](/filings/0001437749-25-016972.md) | [(0.08)](/filings/0001437749-25-026750.md) | [0.02](/filings/0001437749-25-034992.md) | not reported | [0.19](/filings/0001437749-26-017220.md) | [(0.08)](/filings/0001437749-26-027827.md) | [(0.05)](/filings/0001437749-25-034992.md) | not reported | [0.29](/filings/0001437749-26-017220.md) | [(0.03)](/filings/0001437749-26-027827.md) |
| Basic EPS | $ per share | [0.09](/filings/0001437749-24-035032.md) | not reported | [0.14](/filings/0001437749-25-016972.md) | [(0.08)](/filings/0001437749-25-026750.md) | [0.02](/filings/0001437749-25-034992.md) | not reported | [0.20](/filings/0001437749-26-017220.md) | [(0.08)](/filings/0001437749-26-027827.md) | [(0.05)](/filings/0001437749-25-034992.md) | not reported | [0.30](/filings/0001437749-26-017220.md) | [(0.03)](/filings/0001437749-26-027827.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0001513162-23-000144.md) | [1.3](/filings/0001437749-25-007871.md) | [0.2](/filings/0001513162-24-000057.md) | [1.2](/filings/0001513162-24-000088.md) | [0.6](/filings/0001437749-24-035032.md) | [1.9](/filings/0001437749-26-008309.md) | [0.5](/filings/0001437749-25-016972.md) | [0.9](/filings/0001437749-25-026750.md) | [0.6](/filings/0001437749-25-034992.md) | [0.3](/filings/0001437749-26-027827.md) | [0.3](/filings/0001437749-26-017220.md) | [0.3](/filings/0001437749-26-027827.md) |
| Current assets | $m | [46.5](/filings/0001513162-23-000144.md) | [41.4](/filings/0001437749-25-007871.md) | [39.1](/filings/0001513162-24-000057.md) | [37.3](/filings/0001513162-24-000088.md) | [34.5](/filings/0001437749-24-035032.md) | [31.6](/filings/0001437749-26-008309.md) | [29.9](/filings/0001437749-25-016972.md) | [30.7](/filings/0001437749-25-026750.md) | [29.3](/filings/0001437749-25-034992.md) | [25.0](/filings/0001437749-26-027827.md) | [24.1](/filings/0001437749-26-017220.md) | [25.3](/filings/0001437749-26-027827.md) |
| Total assets | $m | [264](/filings/0001513162-23-000144.md) | [264](/filings/0001437749-25-007871.md) | [262](/filings/0001513162-24-000057.md) | [268](/filings/0001513162-24-000088.md) | [275](/filings/0001437749-24-035032.md) | [274](/filings/0001437749-26-008309.md) | [269](/filings/0001437749-25-016972.md) | [272](/filings/0001437749-25-026750.md) | [276](/filings/0001437749-25-034992.md) | [278](/filings/0001437749-26-027827.md) | [274](/filings/0001437749-26-017220.md) | [275](/filings/0001437749-26-027827.md) |
| Current liabilities | $m | [21.0](/filings/0001513162-23-000144.md) | [18.6](/filings/0001437749-25-007871.md) | [12.5](/filings/0001513162-24-000057.md) | [15.0](/filings/0001513162-24-000088.md) | [14.8](/filings/0001437749-24-035032.md) | [15.0](/filings/0001437749-26-008309.md) | [8.2](/filings/0001437749-25-016972.md) | [12.8](/filings/0001437749-25-026750.md) | [16.5](/filings/0001437749-25-034992.md) | [17.0](/filings/0001437749-26-027827.md) | [10.6](/filings/0001437749-26-017220.md) | [13.3](/filings/0001437749-26-027827.md) |
| Long-term debt | $m | [112](/filings/0001513162-23-000144.md) | [123](/filings/0001437749-25-007871.md) | [127](/filings/0001513162-24-000057.md) | [130](/filings/0001513162-24-000088.md) | [138](/filings/0001437749-24-035032.md) | [141](/filings/0001437749-26-008309.md) | [142](/filings/0001437749-25-016972.md) | [141](/filings/0001437749-25-026750.md) | [141](/filings/0001437749-25-034992.md) | [142](/filings/0001437749-26-027827.md) | [143](/filings/0001437749-26-017220.md) | [142](/filings/0001437749-26-027827.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001437749-25-007871.md) | not reported | not reported | [0.0](/filings/0001437749-24-035032.md) | [0.0](/filings/0001437749-26-008309.md) | [0.0](/filings/0001437749-25-016972.md) | [0.6](/filings/0001437749-25-026750.md) | [1.3](/filings/0001437749-25-034992.md) | [1.9](/filings/0001437749-26-027827.md) | [2.5](/filings/0001437749-26-017220.md) | [3.0](/filings/0001437749-26-027827.md) |
| Shareholders' equity | $m | [107](/filings/0001437749-24-035032.md) | [98.0](/filings/0001437749-26-008309.md) | [98.8](/filings/0001437749-25-026750.md) | [98.7](/filings/0001437749-25-034992.md) | [98.5](/filings/0001437749-25-034992.md) | [93.8](/filings/0001437749-26-027827.md) | [94.7](/filings/0001437749-26-027827.md) | [94.6](/filings/0001437749-26-027827.md) | [94.5](/filings/0001437749-25-034992.md) | [94.6](/filings/0001437749-26-027827.md) | [96.1](/filings/0001437749-26-027827.md) | [96.4](/filings/0001437749-26-027827.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.8 d](/filings/0001437749-24-035032.md) | [6.8 d](/filings/0001437749-25-007871.md) | [2.7](/filings/0001437749-25-016972.md) | [6.5 d](/filings/0001437749-25-026750.md) | [2.8 d](/filings/0001437749-25-034992.md) | [7.0 d](/filings/0001437749-26-008309.md) | [5.0](/filings/0001437749-26-017220.md) | [3.6 d](/filings/0001437749-26-027827.md) | [5.5 d](/filings/0001437749-25-034992.md) | [5.1 d](/filings/0001437749-26-008309.md) | [7.0](/filings/0001437749-26-017220.md) | [3.4 d](/filings/0001437749-26-027827.md) |
| Capital expenditure | $m | [18.3 d](/filings/0001437749-24-035032.md) | [22.1 d](/filings/0001437749-25-007871.md) | [11.1](/filings/0001437749-25-016972.md) | [11.9 d](/filings/0001437749-25-026750.md) | [15.4 d](/filings/0001437749-25-034992.md) | [15.3 d](/filings/0001437749-26-008309.md) | [8.6](/filings/0001437749-26-017220.md) | [4.8 d](/filings/0001437749-26-027827.md) | [9.6 d](/filings/0001437749-25-034992.md) | [10.2 d](/filings/0001437749-26-008309.md) | [9.7](/filings/0001437749-26-017220.md) | [2.7 d](/filings/0001437749-26-027827.md) |
| Dividends paid | $m | [0.0 d](/filings/0001437749-24-035032.md) | [0.0 d](/filings/0001437749-25-007871.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-25-007871.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,115](/filings/0001513162-23-000144.md) | [5,137](/filings/0001513162-24-000057.md) | [5,178](/filings/0001513162-24-000088.md) | [5,211](/filings/0001437749-24-035032.md) | [5,257](/filings/0001437749-25-016972.md) | [5,316](/filings/0001437749-25-026750.md) | [5,363](/filings/0001437749-25-034992.md) | [5,425](/filings/0001437749-26-017220.md) | [5,471](/filings/0001437749-26-027827.md) | [5,501](/filings/0001437749-25-034992.md) | [5,536](/filings/0001437749-26-017220.md) | [5,570](/filings/0001437749-26-027827.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,244,006 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-027827.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.